Related Experiment Video

Updated: Jul 10, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Neuroblastoma

Titilope A Ishola1, Dai H Chung

  • 1Sealy Center for Cancer Cell Biology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA.

Surgical Oncology
|November 3, 2007
PubMed

Insights

Neuroblastomas are challenging pediatric cancers. Research focuses on new targets like the MYCN oncogene and angiogenesis, alongside epigenetic regulation and retinoic acid therapy for better treatment strategies.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Molecular Therapeutics

Background:

  • Neuroblastomas present significant clinical challenges despite multimodal therapy advancements.
  • Poor prognostic indicators, including the MYCN oncogene and angiogenesis, are key research areas.
  • Recent discoveries highlight the role of epigenetic regulation and retinoic acid in neuroblastoma pathogenesis.

Purpose of the Study:

  • To explore novel therapeutic targets for neuroblastoma.
  • To investigate the role of MYCN oncogene and angiogenesis in disease progression.
  • To understand the impact of epigenetic modifications and retinoic acid on neuroblastoma.

Main Methods:

  • Review of current research on neuroblastoma targets.
  • Analysis of studies on MYCN oncogene and angiogenesis.
  • Examination of findings related to epigenetic regulation and retinoic acid therapy.

Main Results:

  • MYCN oncogene amplification and angiogenesis are critical poor prognostic factors.
  • Epigenetic dysregulation influences neuroblastoma development.
  • Retinoic acid therapy shows potential in managing neuroblastoma.

Conclusions:

  • Understanding neuroblastoma complexity is crucial for developing innovative treatments.
  • Targeting MYCN, angiogenesis, and epigenetic pathways offers therapeutic potential.
  • Combinational therapy strategies hold promise for improved patient outcomes.

More Related Videos

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...